Does ABEMACICLIB Cause Interstitial lung disease? 323 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 323 reports of Interstitial lung disease have been filed in association with ABEMACICLIB (Verzenio). This represents 2.0% of all adverse event reports for ABEMACICLIB.
323
Reports of Interstitial lung disease with ABEMACICLIB
2.0%
of all ABEMACICLIB reports
91
Deaths
182
Hospitalizations
How Dangerous Is Interstitial lung disease From ABEMACICLIB?
Of the 323 reports, 91 (28.2%) resulted in death, 182 (56.3%) required hospitalization, and 22 (6.8%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
Yes, Interstitial lung disease is listed as a known adverse reaction in the official FDA drug label for ABEMACICLIB.
What Other Side Effects Does ABEMACICLIB Cause?
Diarrhoea (4,988)
Fatigue (1,878)
Nausea (1,682)
Vomiting (943)
Malignant neoplasm progression (890)
Decreased appetite (744)
Death (696)
Asthenia (678)
Drug ineffective (668)
White blood cell count decreased (566)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which ABEMACICLIB Alternatives Have Lower Interstitial lung disease Risk?
ABEMACICLIB vs ABILIFY
ABEMACICLIB vs ABIRATERONE
ABEMACICLIB vs ABIRATERONE\ABIRATERONE
ABEMACICLIB vs ABOBOTULINUMTOXINA
ABEMACICLIB vs ABRAXANE